Therapure Biopharma Inc. wins The CMO Leadership Award

Therapure Biopharma Inc., announced today that it won the 2011 CMO Leadership Award recognizing Therapure as a category leader for both Regulatory and Productivity.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Toronto, Ontario (PRWEB) October 13, 2011

Therapure Biopharma Inc., announced today that it won the 2011 CMO Leadership Award recognizing Therapure as a category leader for both Regulatory and Productivity.

The CMO Leadership Award is based on industry research conducted by Nice Insight and presented by Life Science Leader Magazine. Therapure scored an 81% customer perception (CP) rating in Q3 as published in the October 6, 2011 FiercePharma Manufacturing online article.

In accepting the award, Therapure’s President and Chief Executive Officer, Mr. Nick Green said: “We are delighted and honoured to receive this recognition award as Therapure establishes itself as the solution oriented CMO of choice for the biopharma industry. Compliance and productivity are two essential areas of our business, which are fundamental to customers who trust Therapure to meet their biologic manufacturing and aseptic fill/finish needs. We take great pride in being able to offer an integrated service ranging from the production of cell lines to cGMP manufacturing through to final drug product at our cGMP compliant and state-of-the-art facility located 15 minutes from Toronto’s Lester B. Pearson International Airport”
Theapure will be recognized as an award winner at the 2011 AAPS Annual Meeting and Exposition in Washington, DC where Therapure representatives will be available at booth #1560 to discuss solutions for your outsource manufacturing needs.

About Therapure Biopharma:
Therapure Biobiopharma Inc. is an integrated contract development and manufacturing organization (CDMO) that develops and manufactures (upstream and downstream processing) therapeutic proteins as well as provides aseptic fill/finish services for both complex biologics and small molecules. As a CDMO, Therapure applies greater than 20 years of scientific and biologics manufacturing expertise to develop efficient and innovative solutions to advance your products from discovery to market. Throughout the product development process, Therapure has the ability to provide these services in a fully scalable manner. Established development and manufacturing partnerships with a mixture of companies ranging from start-up to large multi-nationals has provided Therapure with a deep understanding of their client’s project specific needs. With our large, flexible, state-of-the-art facility as well as integrated services, Therapure can provide customer-focused manufacturing solutions giving clients the ability to Start with Us and Stay with Us thereby reducing the time and cost of a technology transfer.

For more information, please visit: http://www.therapurebio.com

Therapure Contacts:

Dina Iezzi
Director, Marketing and Special Projects
(905) 286-6270
diezzi(at)therapurebio(dot)com

###


Contact